
WCM–Q graduates set sights on global impact
Satyendra Pathak
Doha
Weill Cornell Medicine–Qatar (WCM-Q), the Ivy League institution's Middle East campus, continues to live up to its reputation as a premier medical school nurturing some of the most promising doctors of tomorrow.
As this year's cohort of graduates steps out into the world, each one carries a deeply personal story shaped by determination, diversity, and a shared desire to serve.
Among them is Ahamed Lebbe, who moved from Sri Lanka to Qatar at the age of seven. Growing up in Doha, his dream to become a doctor was fueled by the urge to give back to society in a meaningful way.
WCM-Q offered him not only a world-class curriculum but also access to US-based clinical experiences that have prepared him for the next chapter: a residency at the renowned Johns Hopkins Hospital. His goal? A career in gastroenterology.
For Ahamed, WCM-Q offered the ideal blend: a globally recognised Ivy League education within reach of home. What truly impressed him, he shared, was the institution's strong emphasis on patient-centred care, a philosophy that resonated deeply with his own values.
He credits WCM-Q with preparing him for clinical rotations and research opportunities in the United States, which strengthened his residency applications.
He is now headed to Johns Hopkins Hospital to begin his residency in internal medicine, with hopes of eventually specialising in gastroenterology.
Pradipta Paul, a Bangladeshi national born and raised in Qatar, found his calling early in life.
For him, WCM-Q wasn't just an educational institution — it was a bridge between home and a global future. His groundbreaking research on COVID-19 vaccines, under the mentorship of Dr Laith Abu-Raddad, professor of population health sciences, and director of the biostatistics, epidemiology, and biomathematics research core at WCM-Q, won him accolades and helped shape his approach to patient care.
His interest in medicine was sparked in high school, and he was determined to pursue it while remaining close to his family.
'WCM-Q allowed me to do what I loved, while staying rooted,' he said.
His time at the college helped him develop a strong aptitude for research, which began as early as his second year in the pre-medical track. Over the years, this interest evolved into a deep commitment.
He believes this experience not only honed his analytical and communication skills but will also help him counsel patients with vaccine hesitancy in clinical practice.
He is now headed to Rochester General Hospital to begin his residency in internal medicine, with ambitions to specialise further in cardiology or gastroenterology.
For American-born Kevin Zhai, the choice to study medicine in Qatar was deliberate.
Eschewing offers from US schools, he embraced the cultural diversity and intimacy of WCM-Q's campus, where he thrived in leadership roles and led pioneering research in nanomedicine.
He will soon begin his residency in neurology in the United States.
'I knew I would receive the same Cornell curriculum here, but with the added benefit of understanding a different culture and healthcare system,' he said.
What stood out for Kevin was the more intimate academic environment compared to large US universities.
With smaller class sizes and strong faculty access, he found ample opportunities for leadership and innovation. Over the past few years, he led a research team as principal investigator, exploring the intersections of nanotechnology and medicine.
His work, funded through various grants and published in peer-reviewed journals, has contributed to a growing body of knowledge in biomedical innovation.
He will now return to the US to begin his residency in neurology.
Another graduate Mohammad Saad Javed, originally from Pakistan but raised in the UK, has been living in Qatar for the past decade.
He joined WCM-Q at a time when it was the sole provider of American-style medical education in the country. Now, with several years of rigorous training behind him, he appreciates the institution's holistic and supportive learning environment.
'The faculty are incredibly engaged. They truly care about student growth,' he shared.
Though he didn't highlight a specific research project, he expressed pride in simply completing the programme and stepping into the next phase of his career.
He is now preparing to begin his residency in psychiatry in Florida.
Then, there's the story of Omar Mourad and Aisha Serpedin — two students whose paths converged both professionally and personally.
Amar, a Syrian national raised in Qatar, and Aisha, who moved from the US with her Romanian-American family, were drawn to WCM-Q for similar reasons: the opportunity to receive an American education close to home. They are now headed to the University of Vermont for their residencies with Amar specialising in internal medicine and Aisha in neurology — with plans to return and serve the region they call home.
'There are unique cases and healthcare challenges in this region. Studying medicine here gave me exposure to both American medical standards and local cultural contexts,' Aisha said.
For Amar, treating Arabic-speaking patients and practising in a community he knew well was a key motivation.
Both valued the professionalism and high standards of education that WCM-Q offered.
As fate would have it, their shared journey extended beyond the classroom.
The couple matched together at the University of Vermont — Aisha into neurology and Amar into internal medicine. They hope to return to Qatar after their US training to serve the region with their acquired expertise.
From aspiring physicians to future specialists in internal medicine, neurology, psychiatry, gastroenterology, and cardiology, these graduates are now set to begin their residencies in top institutions across the United States.
They leave behind a legacy of academic excellence, groundbreaking research, and a strong commitment to serve. As they step into the global medical landscape, their stories remain anchored in the halls of Weill Cornell Medicine–Qatar, an institution that has empowered them to heal, to lead, and to inspire.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Jazeera
a day ago
- Al Jazeera
What is driving a surge in COVID cases in India, other countries?
India has reported a sudden rise in COVID cases, starting from late May. Authorities said the number of active cases of the disease has surpassed 5,000. India is the latest of a number of countries to report an uptick in COVID cases this year as, more than five years after the virus was declared a global pandemic, waves of new strains continue to emerge. Here is what we know about the new variant of COVID and where it has spread: As of Thursday this week, there are 5,364 active cases in India, according to India's Ministry of Health and Family Welfare. Since January 1, more than 4,700 people have recovered from COVID in India, while 55 people have died from the virus. The main coronavirus variant causing a new spread of the disease is known as NB.1.8.1. Cases caused by this variant have been reported in the United Kingdom, the United States, Australia, Thailand, China and Hong Kong, among other countries. It is now the dominant variant in China and Hong Kong. A second variant, LF.7, is also responsible for some of the cases in India. The UK Health Security Agency (UKHSA) said it had recorded 13 cases of the NB.1.8.1 variant in England, with 'small numbers' detected across the UK. By late April, NB.1.8.1 comprised about 10.7 percent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 percent one month before. The Omicron variant NB.1.8.1 was first detected in January this year. It is a 'recombinant' variant, which means it has arisen from the genetic mixing of two or more existing variants. On May 23, 2025, the WHO declared the NB.1.8.1 strain a 'variant under monitoring' (VUM). According to a 2023 definition by the WHO, a VUM is a variant which has undergone genetic changes that scientists believe could potentially affect the behaviour of the virus; early data suggests that this variant can grow faster or spread more easily than others, but this has not yet been confirmed. The evidence of the variant's impact on health, immunity or transmission is still unclear. While the NB.1.8.1 strain is still being researched, the evidence so far suggests that the strain may spread more easily, virologist Lara Herrero wrote for The Conversation on May 28. Researchers using lab-based models have found that of several variants tested, the new strain had the strongest ability to bind to human cell receptors. This suggests that the strain may 'infect cells more efficiently than earlier strains', Herrero wrote. 'It is more transmissible,' Subhash Verma, a professor of microbiology and immunology at the University of Nevada, Reno School of Medicine, told CBS News. Common symptoms of the NB.1.8.1 strain include a sore throat, cough, muscle aches, fever and nasal congestion. It can also cause gastrointestinal symptoms such as nausea and diarrhoea. Vaccines remain a powerful defence against COVID infections, severe sickness, hospitalisation and death, clinicians say. However, virologist Herrero wrote that besides spreading more easily, NB.1.8.1 may 'partially sidestep' immunity gained from the vaccines or prior infection. For now, health authorities say current COVID jabs are expected to be effective against this coronavirus variant and protect people from severe illness. Health experts worldwide say there is no evidence that the new strain of the coronavirus is more severe or deadly than any previous strain. However, it does appear to spread more easily. Since COVID spreads through airborne particles and droplets, the spread of the virus can be prevented by getting tested if symptoms show, wearing a mask and social distancing, clinicians have advised.


Qatar Tribune
2 days ago
- Qatar Tribune
Israeli strikes kill at least 52 across Gaza
Agencies Gaza At least 52 Palestinians were killed in Israeli strikes across Gaza on Thursday, medical sources told Al Jazeera, as a US-backed group said it would reopen two aid distribution centres in the war-torn Strip. At least seven people, including four journalists, were killed in an Israeli drone attack on Al Ahli Baptist Hospital in Gaza City, medical sources said. Palestinian health authorities confirmed the deaths of four journalists. Gaza's Government Media Office said the deaths raised the total number of journalists killed in Israel's war on Gaza since October 2023 to 224. The attack comes as the Gaza Humanitarian Foundation (GHF) – a shadowy organisation backed by the United States and Israel – said it would open two aid distribution centres in the war-torn territory on Thursday after a full-day closure on Wednesday. It said in a post on Facebook that it would reopen two centres in the Rafah area of southern Gaza. It did not say when aid distribution would resume. The GHF earlier said its sites in Gaza would not open at their usual time due to maintenance and repair work and strongly urged aid seekers travelling to its locations to 'follow the routes' set by the Israeli military to 'ensure safe passage'. The Israeli military warned Palestinians on Wednesday not to approach GHF aid distribution sites while 'reorganisation work' was under way, saying that access roads to those locations would be 'considered combat zones'. The suspension of GHF's distribution of food supplies in Gaza comes after Israeli forces opened fire on Palestinians seeking aid for a fourth time near a GHF distribution site in Rafah, southern Gaza, early on Tuesday. The Israeli attack killed at least 27 people and injured about 90 more, according to Gaza's Ministry of Health. The International Committee of the Red Cross (ICRC) has confirmed that it received a 'mass casualty influx of 179 cases' after Sunday's attack, including 21 patients who were 'declared dead upon arrival'. Women and children were among the casualties, the group said.


Qatar Tribune
3 days ago
- Qatar Tribune
UNICEF spokesman ‘shocked' by extent of malnutrition in Gaza
UNICEF spokesman James Elder, currently in Gaza, has described the 'horrors' he witnessed within just 24 hours. Speaking from al-Mawasi, Elder told Al Jazeera that Gaza's hospitals and streets are filled with malnourished children. 'I'm seeing teenage boys in tears, showing me their ribs,' he said, noting that children were pleading for food. He described people so desperate that they walk kilometres to aid centres – despite knowing 'massacres' have recently taken place there. 'Imagine knowing there'd be a massacre, but being so desperate to feed your family that you still go,' he said, blaming the Israel-US-backed Gaza Humanitarian Foundation for enabling the violence and then shutting down operations without delivering enough aid. (Agencies)